Megamox Forte (Amoxicillin, Clavulanic Acid)

Amoxicillin interferes with bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, causing cell lysis. Clavulanic acid binds irreversibly to beta‑lactamase enzymes, preventing them from degrading amoxicillin, thereby extending the antibiotic’s activity against resistant organisms.

The dosage of Megamox Forte is determined by the prescribing clinician based on the infection type, severity, patient age, weight, and renal function. Only a qualified health professional should set the regimen, and patients should follow the prescription exactly.

Safety in pregnancy and lactation has not been definitively established. The drug should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Megamox Forte combines a penicillin (amoxicillin) with a beta‑lactamase inhibitor (clavulanic acid), offering broader coverage than amoxicillin alone and better activity against beta‑lactamase‑producing bacteria. Compared with third‑generation cephalosporins, it provides similar efficacy for many common infections but may have a different side‑effect profile.

Store Megamox Forte at room temperature, below 25 °C. Keep the tablets in the original packaging to protect them from moisture and light. Do not store in a bathroom or near a heat source.

Megamox Forte is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with food can reduce gastrointestinal upset. The exact schedule (e.g., twice daily) is set by the prescriber.

Serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome or toxic epidermal necrolysis. Patients should seek immediate medical attention if they experience difficulty breathing, severe rash, or persistent diarrhea.

Megamox Forte should be avoided in individuals with a known hypersensitivity to amoxicillin, any penicillin, or clavulanic acid. It is also contraindicated in patients who have previously experienced severe reactions to beta‑lactam antibiotics.